GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 60 days ( 0 % )
Last Price $0.0135 0 %
High/ Low $0.0135 - $0.0135 0%
Chg 7 Days N/A $0.0135 $0.0135
Chg 30 Days N/A $0.0135 $0.0135
Chg 12 mos -98.61 % $0.97 $0.0135
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -96.35 % Width: 108.66 %
Pred. range - 3 mos $0.0135 - $0.0135 0 % - 0 %
Pred. range - 12 mos N/A - $0.0017 -100.00 % - -87.62 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2024-01-02 - 66 days
Long MA avg 12 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 12 mos Sell 2023-04-13 - 247 days
Pivot Short Buy 2024-04-04 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Athersys

Athersys Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study f... ATHX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT